Stay updated on Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial

Sign up to get notified when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now presents the study record for a Phase 2 trial comparing immune checkpoint therapy with target therapy for patients with advanced hepatocellular carcinoma and hepatitis B. It includes study participation details, treatment arms, outcome measures, contacts, and record dates.
    Difference
    56%
    Check dated 2026-11-07T12:27:09.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T13:29:02.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces an NIH transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record itself is still replaced by a 403 error.
    Difference
    1%
    Check dated 2026-10-24T12:45:41.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:19:31.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-10T12:44:40.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now displayed on the page. A large set of non-core metadata and term blocks were removed, simplifying the study details view.
    Difference
    19%
    Check dated 2026-09-19T18:47:51.000Z thumbnail image

Stay in the know with updates to Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.